Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Factors affecting directional migration of bone marrow mesenchymal stem cells to the injured spinal cord

Factors affecting directional migration of bone marrow mesenchymal stem cells to the injured spinal cord

Neural Regeneration Research, 2014 · DOI: 10.4103/1673-5374.141804 · Published: September 1, 2014

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

This study investigates how bone marrow mesenchymal stem cells (BMSCs) migrate to the site of a spinal cord injury and how this migration can be influenced. The research focuses on the role of a protein called microtubule-associated protein 1B (MAP1B) and its phosphorylated form (P1-MAP1B) in directing this migration. The study also examines the involvement of specific signaling pathways (PI3K and ERK1/2) in regulating the phosphorylation of MAP1B and, consequently, the efficiency of BMSC migration towards the injured spinal cord.

Study Duration
Not specified
Participants
96 healthy 6-month-old New Zealand rabbits
Evidence Level
Level 3; Animal study

Key Findings

  • 1
    The expression of P1-MAP1B in BMSCs is affected by okadaic acid (a protein phosphatase 2A inhibitor) and N-acetyl-D-erythro-sphingosine (a protein phosphatase 2A stimulator).
  • 2
    The migration of BMSCs to the injured spinal cord is poorer in cells exposed to okadaic acid and N-acetyl-D-erythro-sphingosine compared to untreated cells.
  • 3
    Inhibiting PI3K leads to an elevated expression of P1-MAP1B, while inhibiting ERK1/2 causes a reduction in expression.

Research Summary

This study explores the factors influencing the directional migration of bone marrow mesenchymal stem cells (BMSCs) towards injured spinal cord tissue, focusing on the role of microtubule-associated protein 1B (MAP1B). The researchers manipulated the phosphorylation of MAP1B using agonists and inhibitors of protein phosphatase 2A and observed the effects on BMSC migration in a rabbit model of spinal cord contusion. The study found that PI3K and ERK1/2 pathways modulate MAP1B phosphorylation and consequently affect the migratory efficiency of BMSCs towards the injured spinal cord.

Practical Implications

Therapeutic target identification

MAP1B phosphorylation can be a potential therapeutic target to improve BMSC migration.

Enhancing cell therapy

Modulating PI3K and ERK1/2 pathways may enhance BMSC migration in spinal cord injury treatment.

Optimizing transplantation strategies

Understanding the mechanisms that regulate BMSC migration can help optimize cell transplantation strategies for spinal cord repair.

Study Limitations

  • 1
    The study was conducted on a rabbit model, and the results may not be directly applicable to humans.
  • 2
    The specific chemokines involved in regulating targeted migration were not fully determined.
  • 3
    The long-term effects of modulating MAP1B phosphorylation on spinal cord repair were not investigated.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury